risks of glp 1 Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Long-Term Risks of GLP-1 Drugs:

Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)

Take this list with you to the grocery store to support your health goals including avoiding side effects and staying nourished.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.

We aimed ...

In fact, the similar pathological mechanisms shared by PD and T2DM have inspired several studies on the therapeutic potential of T2DM drugs against PD, among which glucagon-like peptide-1 receptor (GLP-1R) agonists are promising candidates

Discover how next-generation oral GLP-1 therapies are transforming weight management by breaking through the stomachs toughest barriers and opening the door to powerful, needle-free metabolic treatments.